N. Sbar: search on Z-Library

Fundraising September 15, 2024 – October 1, 2024 About fundraising

The world's largest scientific articles store. 70,000,000+ articles for free.

Fundraising September 15, 2024 – October 1, 2024

Z-Library is one of the largest online libraries in the world that contains over 17,000,000 books and 84,837,000 articles. We aim to make literature accessible to everyone. Today (September 15, 2024) we've started additional fundraising to project maintenance and development.

Also UNLIMITED downloads (for 31 days after the day of making donation) are available for ALL contributors who will donate during the fundraising period till October 1, 2024.

About fundraisingRead more

Make a donation

51

Dacomitinib versus erlotinib in patients with EGFR-mutated advanced nonsmall-cell lung cancer (NSCLC): pooled subset analyses from two randomized trials

Ramalingam, S. S., O'Byrne, K., Boyer, M., Mok, T., Jänne, P. A., Zhang, H., Liang, J., Taylor, I., Sbar, E. I., Paz-Ares, L.

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 238 KB

english, 2016

52

Phase I Study of Sequential Administration of Topotecan and 5-Fluorouracil in Patients with Advanced Malignancies

Sbar, Eric I., Khatri, Jamil, Rodman, W. David, Tritschler, Lori, Goldberg, Jack, Grana, Generosa, Devereux, Linda, Hageboutros, Alexandre

Journal:

Cancer Investigation

Year:

2002

Language:

english

File:

PDF, 235 KB

english, 2002

53

O1-9-1ARCHER 1050: first-line dacomitinib vs gefitinib for advanced NSCLC in patients with EGFR activating mutation(s)

Nakagawa, Kazuhiko, Mok, Tony SK., Wu, Yi-Long, Rosell, Rafael, Tsuji, Fumito, Wang, Tao, Sbar, Eric

Journal:

Annals of Oncology

Year:

2015

Language:

english

File:

PDF, 34 KB

english, 2015

54

Dacomitinib versus erlotinib in patients with EGFR-mutated advanced nonsmall-cell lung cancer (NSCLC): pooled subset analyses from two randomized trials

Ramalingam, S. S., O'Byrne, K., Boyer, M., Mok, T., Jänne, P. A., Zhang, H., Liang, J., Taylor, I., Sbar, E. I., Paz-Ares, L.

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 104 KB

english, 2016

55

Pulmonary Alveolar Proteinosis: A Review of the Literature

SANDERS, MARVIN, KAHAN, MILES, SBAR, SYDNEY

Journal:

Year:

1962

Language:

english

File:

PDF, 683 KB

english, 1962

56

What is causing this patientʼs acute abdomen?

Porter, Cliff A., Sbar, Alan, Misra, Subhasis

Journal:

Journal of the American Academy of Physician Assistants

Year:

2015

Language:

english

File:

PDF, 175 KB

english, 2015

57

Isolated chronic tricuspid insufficiency due to closed chest trauma: Report of a case with long-term follow-up

Vijayanagar, R., Bognolo, D. A., Harrison, E., Raju, B. M., Eckstein, P. F., Sbar, S.

Journal:

Clinical Cardiology

Year:

1979

Language:

english

File:

PDF, 411 KB

english, 1979

58

A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer

Lacouture, M. E., Keefe, D. M., Sonis, S., Jatoi, A., Gernhardt, D., Wang, T., Doherty, J. P., Giri, N., Nadanaciva, S., O'Connell, J., Sbar, E., Piperdi, B., Garon, E. B.

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 213 KB

english, 2016

59

Surgical Management of the Small Aortic Annulus

Pupello, Dennis F., Blank, Richard H., Bessone, Luis N., Harrison, Eric, Sbar, Sheldon

Journal:

Year:

1978

Language:

english

File:

PDF, 1.47 MB

english, 1978

60

Chronic Tricuspid Insufficiency

SBAR, SHELDON, DAICOFF, GEORGE, NIGHTINGALE, DAVID, RAMSEY, HOWARD W., SWANICK, EDWARD J.

Journal:

Southern Medical Journal

Year:

1973

File:

PDF, 201 KB

1973

61

Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers

Yu, Helena A., Ahn, Myung-Ju, Cho, Byoung Chul, Gerber, David E., Natale, Ronald B, Socinski, Mark A., Giri, Nagdeep, Quinn, Susan, Sbar, Eric, Zhang, Hui, Giaccone, Giuseppe

Journal:

Year:

2017

Language:

english

File:

PDF, 230 KB

english, 2017

62

Dacomitinib versus gefitinib as first-line treatment for patients with EGFR -mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial

Wu, Yi-Long, Cheng, Ying, Zhou, Xiangdong, Lee, Ki Hyeong, Nakagawa, Kazuhiko, Niho, Seiji, Tsuji, Fumito, Linke, Rolf, Rosell, Rafael, Corral, Jesus, Migliorino, Maria Rita, Pluzanski, Adam, Sbar, Er

Journal:

The Lancet Oncology

Year:

2017

Language:

english

File:

PDF, 625 KB

english, 2017

63

Comparison of model-based generalized regression neural network and prestack inversion in predicting Poisson's ratio in Heidrun Field, North Sea

Keynejad, Saba, Sbar, Marc L., Johnson, Roy A.

Journal:

The Leading Edge

Year:

2017

Language:

english

File:

PDF, 8.32 MB

english, 2017

64

P3.01-012 Symptom Impact of First-Line Dacomitinib versus Gefitinib in EGFR-Positive NSCLC: Results from a Randomized Phase 3 Study

Migliorino, M.R., Mok, T., Wu, Y., Zhou, X., Lee, K.H., Nakagawa, K., Niho, S., Tsuji, F., Linke, R., Rosell, R., Corral, J., Pluzanski, A., Sbar, E., Sandin, R., Reisman, A., Wang, T., White, J.L., C

Journal:

Journal of Thoracic Oncology

Year:

2017

Language:

english

File:

PDF, 418 KB

english, 2017

65

P3.01-072 Dacomitinib Versus Gefitinib for First-Line Treatment of Advanced EGFR+ NSCLC in Japanese Patients (ARCHER 1050)

Nakagawa, K., Ohyanagi, F., Kato, T., Takahashi, T., Kaneda, H., Nogami, N., Niho, S., Yamamoto, N., Fujita, Y., Zhang, H., Sbar, E., Wang, T., Linke, R., Tsuji, F., Mok, T.

Journal:

Journal of Thoracic Oncology

Year:

2017

Language:

english

File:

PDF, 265 KB

english, 2017

66

OA 05.01 First-Line Dacomitinib versus Gefitinib in Advanced Non-Small-Cell Lung Cancer with EGFR Mutation Subgroups

Wu, Y., Cheng, Y., Zhou, X., Lee, K.H., Nakagawa, K., Niho, S., Tsuji, F., Rosell, R., Corral, J., Migliorino, M.R., Pluzanski, A., Linke, R., Sbar, E., Wang, T., Zhang, H., Mok, T.

Journal:

Journal of Thoracic Oncology

Year:

2017

Language:

english

File:

PDF, 193 KB

english, 2017

67

Rhabdomyolysis secondary to systemic lupus erythematosus

Nguyen, Daniel, Alsaati, Farah, Deitrick, Jena, Azhar, Kamel, Sbar, Evelyn

Journal:

Autoimmunity Highlights

Year:

2018

Language:

english

File:

PDF, 1.04 MB

english, 2018

68

MA26.11 Effects of Dose Modifications on the Safety and Efficacy of Dacomitinib for EGFR Mutation-Positive NSCLC

Mok, T., Nakagawa, K., Rosell, R., Lee, K., Corral, J., Migliorino, M.R., Pluzanski, A., Linke, R., Devgan, G., Sbar, E., Quinn, S., Wang, T., Wu, Y.

Journal:

Journal of Thoracic Oncology

Year:

2018

Language:

english

File:

PDF, 187 KB

english, 2018

69

Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer and EGFR -Activating Mutations

Mok, Tony S., Cheng, Ying, Zhou, Xiangdong, Lee, Ki Hyeong, Nakagawa, Kazuhiko, Niho, Seiji, Lee, Min, Linke, Rolf, Rosell, Rafael, Corral, Jesus, Migliorino, Maria Rita, Pluzanski, Adam, Sbar, Eric I

Journal:

Journal of Clinical Oncology

Year:

2018

Language:

english

File:

PDF, 835 KB

english, 2018

70

Substernocleidomastoid Muscle Neck Lipoma: An Isolated Case Report

Rico, Ferdinand, Hoang, Dustin, Lung, John, Puccio, Olivia, Brito, Michelle, Nazim, M. Haris, Sbar, Alan

Journal:

Case Reports in Surgery

Year:

2019

Language:

english

File:

PDF, 6.61 MB

english, 2019

71

Laparoscopic excision of a retroperitoneal mucinous cystic neoplasm: A case report

Lung, John, Gracey, Allison, Rosales, Abigail, Bashover, Eva, Sbar, Alan, Nazim, M. Haris, Rico, Ferdinand

Journal:

International Journal of Surgery Case Reports

Year:

2019

Language:

english

File:

PDF, 1.25 MB

english, 2019

72

916PHealth-related quality of life (HRQoL) and updated follow-up from KEYNOTE-057: Phase II study of pembrolizumab (pembro) for patients (pts) with high-risk (HR) non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guérin (BCG)

de Wit, R, Kulkarni, G S, Uchio, E, Boormans, J L, Roumiguié, M, Krieger, L E M, Singer, E A, Bajorin, D F, Kamat, A M, Grivas, P, Seo, H K, Nishiyama, H, Konety, B R, Saretsky, T, Li, H, Nam, K, Sbar

Journal:

Annals of Oncology

Year:

2019

File:

PDF, 95 KB

2019

73

990TiPPhase III LEAP-011 trial: First-line pembrolizumab with lenvatinib in patients with advanced urothelial carcinoma ineligible to receive platinum-based chemotherapy

Loriot, Y, Balar, A, de Wit, R, Garcia, J A, Grivas, P, Matsubara, N, Frenkl, T L, Sbar, E, Jia, X C, Fouad, T, Siefker-Radtke, A O

Journal:

Annals of Oncology

Year:

2019

File:

PDF, 84 KB

2019

74

Seismic trends and travel-time residuals in eastern North America and their tectonic implications

FLETCHER, JON B., SBAR, MARC L., SYKES, LYNN R.

Journal:

Base of the Kiaman Its definition and global stratigraphic significance

Year:

1978

File:

PDF, 1.16 MB

1978

75

783P Real-world outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) who received first- (1L) or second-line (2L) PD-1 and PD-L1 inhibitors in the United States (US)

Boyd, M., Annavarapu, S., Doshi, G.K., Imai, K., Sbar, E.I., Godwin, J.L., Li, H., Sonpavde, G.

Journal:

Annals of Oncology

Year:

2020

File:

PDF, 85 KB

2020

76

Long-Term Outcomes and Costs Among BCG-treated High-Risk Non-Muscle Invasive Bladder Cancer Patients in an Equal Access Setting

Williams, SB, Howard, LE, Foster, ML, Klaassen, Z, Li, H, Sieluk, J, Imai, K, Sbar, EI, De Hoedt, AM, Freedland, SJ

Journal:

Urologic Oncology: Seminars and Original Investigations

Year:

2020

File:

PDF, 415 KB

2020